Evidence map›Paper›PMID 26287178›Full record

ArticleInternational journal of molecular sciences2015

Tangential Flow Ultrafiltration Allows Purification and Concentration of Lauric Acid-/Albumin-Coated Particles for Improved Magnetic Treatment.

Jan Zaloga, Marcus Stapf, Johannes Nowak, Marina Pöttler, Ralf P Friedrich, Rainer Tietze, Stefan Lyer, Geoffrey Lee, Stefan Odenbach, Ingrid Hilger and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jan ZalogaSection of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany. jan.zaloga@uk-erlangen.de.
Marcus StapfInstitute for Diagnostic and Interventional Radiology, University Hospital Jena, 07747 Jena, Germany. Marcus.Stapf@med.uni-jena.de.
Johannes NowakChair of Magnetofluiddynamics, Measuring and Automation Technology, Technische Universität Dresden, 01069 Dresden, Germany. johannes.nowak@tu-dresden.de.
Marina PöttlerSection of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany. marina.poettler@uk-erlangen.de.
Ralf P FriedrichSection of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany. ralf.friedrich@uk-erlangen.de.
Rainer TietzeSection of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany. rainer.tietze@uk-erlangen.de.
Stefan LyerSection of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany. stefan.lyer@uk-erlangen.de.
Geoffrey LeeDivision of Pharmaceutics, Friedrich Alexander University Erlangen-Nuremberg, 91058 Erlangen, Germany. geoff.lee@fau.de.
Stefan OdenbachChair of Magnetofluiddynamics, Measuring and Automation Technology, Technische Universität Dresden, 01069 Dresden, Germany. stefan.odenbach@tu-dresden.de.
Ingrid HilgerInstitute for Diagnostic and Interventional Radiology, University Hospital Jena, 07747 Jena, Germany. Ingrid.Hilger@med.uni-jena.de.
Christoph AlexiouSection of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Stiftungsprofessur for Nanomedicine, University Hospital Erlangen, 91054 Erlangen, Germany. c.alexiou@web.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superparamagnetic iron oxide nanoparticles (SPIONs) are frequently used for drug targeting, hyperthermia and other biomedical purposes. Recently, we have reported the synthesis of lauric acid-/albumin-coated iron oxide nanoparticles SEON(LA-BSA), which were synthesized using excess albumin. For optimization of magnetic treatment applications, SPION suspensions need to be purified of excess surfactant and concentrated. Conventional methods for the purification and concentration of such ferrofluids often involve high shear stress and low purification rates for macromolecules, like albumin. In this work, removal of albumin by low shear stress tangential ultrafiltration and its influence on SEON(LA-BSA) particles was studied. Hydrodynamic size, surface properties and, consequently, colloidal stability of the nanoparticles remained unchanged by filtration or concentration up to four-fold (v/v). Thereby, the saturation magnetization of the suspension can be increased from 446.5 A/m up to 1667.9 A/m. In vitro analysis revealed that cellular uptake of SEON(LA-BSA) changed only marginally. The specific absorption rate (SAR) was not greatly affected by concentration. In contrast, the maximum temperature Tmax in magnetic hyperthermia is greatly enhanced from 44.4 °C up to 64.9 °C by the concentration of the particles up to 16.9 mg/mL total iron. Taken together, tangential ultrafiltration is feasible for purifying and concentrating complex hybrid coated SPION suspensions without negatively influencing specific particle characteristics. This enhances their potential for magnetic treatment.

Indexed as

AnimalsCattleColloidsHumansHyperthermia, InducedJurkat CellsLauric AcidsMagneticsMagnetite NanoparticlesSerum Albumin, BovineSurface PropertiesUltrafiltrationColloidslauric acidLauric AcidsMagnetite NanoparticlesSerum Albumin, Bovinehyperthermiananoparticle concentrationnanoparticle purificationspecific absorption rate (SAR)superparamagnetic iron oxide nanoparticles (SPIONs)tangential ultrafiltration

Identifiers

PMID26287178
PMCPMC4581297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.